HIGHLIGHTS
- who: Steven A. Manobianco from the Thomas Jefferson University Hospital, Jefferson University Hospitals, Philadelphia, PA, United States, Department of have published the paper: Novel Mechanisms for Post-Transplant Maintenance Therapy in Acute Myeloid Leukemia, in the Journal: (JOURNAL)
- how: Their data showed that AZA maintenance therapy improved event-free survival (EFS) (p=0.019) and OS (p=0.011) .
- future: This is a relatively new direction in AML treatment and there is still much more to be studied regarding the combination of these drugs. A 2021 phase II clinical trial of 6 measurable . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.